InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Ryan Barbara, Director. Officer active across 4 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 16 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 15 January 2022. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
6,518 shares0Common StockSEC:0001827169-26-000013
6,518 shares0Common StockSEC:0001827169-26-000013:0
2,019 shares@ US$8.798.5% of flowCommon StockSEC:0000950170-25-033523:0
24,229 shares@ US$0.738.3% of flowCommon StockSEC:0000950170-24-132525:0
21,649 shares@ US$0.828.0% of flowCommon StockSEC:0000950170-24-103750:0
17,841 shares@ US$0.998.1% of flowCommon StockSEC:0000950170-24-069215:0
18,685 shares@ US$0.958.2% of flowCommon StockSEC:0000950170-24-026422:0
17,068 shares@ US$1.048.1% of flowCommon StockSEC:0000950170-23-068322:0
12,158 shares@ US$1.468.1% of flowCommon StockSEC:0000950170-23-046774:0
10,086 shares@ US$1.768.2% of flowCommon StockSEC:0000899243-23-014414:0
8,493 shares@ US$2.098.3% of flowCommon StockSEC:0000899243-23-006913:0
6,801 shares@ US$2.618.5% of flowCommon StockSEC:0000899243-22-037650:0
13,550 shares@ US$2.6217.7% of flowCommon StockSEC:0000899243-22-031529:0
10,526 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015911:0
Ideal exit: 26 Feb 2023 (T+270)
8,588 shares0Common StockSEC:0001493152-22-001529
8,588 shares0Common StockSEC:0001493152-22-001529:0
16 of 16 declarations
About Ryan Barbara
Barbara Ryan serves as a Board Member of Indivior Pharmaceuticals, Inc. and INVO Bioscience, Inc. She participates in the governance of these companies by overseeing operations and contributing to strategic decision-making. Her role is essential in ensuring compliance and transparency in their activities.
